# CSPC NBP Pharmaceutical

CSPC NBP Pharmaceutical is a Corporate Investor based in Shijiazhuang, China.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Shijiazhuang, China
- **Region:** Asia
- **Address:** Shijiazhuang, Hebei, China
- **Founded:** 2003
- **Assets under management:** Undisclosed
- **Website:** e-cspc.com
- **LinkedIn:** linkedin.com/company/cspc-nbp-pharmaceutical-co.-ltd.

## Regulatory record

- **Reports private funds:** No

## About

CSPC NBP Pharmaceutical was established in 2003. Cai Dongchen serves as the ultimate controlling person via his chairmanship of CSPC Pharmaceutical Group Limited, the 100 percent indirect owner. The firm focuses on pharmaceutical production and licensing. Asset classes center on intellectual property and industrial real estate tied to its Shijiazhuang production base. It maintains licensing agreements with AstraZeneca and BeiGene for AI-driven small-molecule programs. Geographic activity remains concentrated in China with global IP reach. No public data exist on team size or additional offices. The firm lists membership in the China Pharmaceutical Equipment Association and the China Vaccine Industry Association. A related philanthropic vehicle is the Hebei CSPC Puen Charity Foundation. Ownership flows through CSPC Pharmaceutical Group Limited, with Key Honesty Limited holding shares linked to employee awards. This structure separates operating control from direct family ownership disclosure.

## Sectors

- Healthcare Services

## People

- Cai Dongchen — Chairman of CSPC Pharmaceutical Group

## Questions

### Who runs investment decisions at CSPC NBP Pharmaceutical?

Cai Dongchen holds ultimate control as chairman of the parent CSPC Pharmaceutical Group. Decisions align with group-level pharmaceutical strategy.

### Does CSPC NBP Pharmaceutical participate in fund commitments or only direct deals?

Activity centers on direct licensing partnerships and internal production assets. No fund commitments appear in available records.

### How is CSPC NBP Pharmaceutical related to CSPC Pharmaceutical Group Limited?

CSPC Pharmaceutical Group Limited serves as the 100 percent indirect owner. The relationship structures all operational and investment activity.

## Related profiles

- [CSN Inova Ventures](https://altss.com/profile/csn-inova-ventures)
- [CSP DAO](https://altss.com/profile/csp-dao)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/cspc-nbp-pharmaceutical

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology